A CASE-CONTROL STUDY: MATERNAL SERUM CYSTATIN-C LEVELS IN THIRD TRIMESTER OF PREECLAMPTIC AND NORMOTENSIVE PREGNANTS
Abstract
Keywords
Full Text:
PDFReferences
disease: outcome in Indian women. J Womens Health (Larchmt). 2003;12(10):1019-1025
Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR—history, indications, and future research. Clin Biochem 2005; 38: 1-8.
Afonso S, Romagnano L, Babiarz B. The expression and function of cystatin C and cathepsin B andcathepsin L during mouse embryo implantation and placentation. Development 1997; 124: 3415- 25.
Kristensen K, Larsson I, Hansson SR. Increased cystatin C expression in the pre-eclamptic placenta. Mol Hum Reprod 2007; 13: 189-95.
Strevens H, Wide-Swensson D, Grubb A, Hansen A, Horn T, Ingemarsson I, et al. Serum cystatin C reflects glomerular endotheliosis in normal, hypertensive and pre-eclamptic pregnancies. BJOG 2003; 110: 825-30.
Novakov Mikic A, Cabarkapa V, Nikolic A, Maric D, Brkic S, Mitic G, Ristic M, Stosic Z. Cystatin C in pre-eclampsia. J Matern Fetal Neonatal Med. 2012 Jul;25(7):961-5
Apeksha Niraula, Madhab Lamsal, Nirmal Baral, Shankar Majhi, Seraj Ahmed Khan, Pritha Basnet, and Kashyap Dahal. Cystatin-C as a Marker for Renal Impairment in Preeclampsia. J Biomark. 2017; 2017: 7406959
Cimona Lyn Saldanha, Shabnum Ara, Tabassum Parvez. The role of cystatin c in the prediction of outcome in hypertensive disorders of pregnancy. Int J Reprod Contracept Obstet Gynecol. 2017;May6(5):1825-1828
Refbacks
- There are currently no refbacks.